Two spine companies launched public offerings since Feb. 26.
Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering. The company listed 5,175,000 units at 58 cents each.
Bone Biologics, a company focused on spine fusion products, announced a $2 million public offering. The public offering includes 781,251 shares of its common stock for $2.56 per share.
Centinel Spine, a global medical device company, reported a 33% increase in year-over-year revenue during the first quarter of 2025. …
Aurora Spine reported $17.6 million in revenue during fiscal year 2024, an increase of more than 20% over the previous…
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and…
Comments are closed.